Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Pro-Dex Inc (PDEX) Insider Trading Activity
Healthcare • Medical Instruments & Supplies • 146 employees
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Total Value
-$1,850,389.26
Total Shares
-34,127
Average Trade Value
-$63,806.53
Most Active Insider
Cabillot Raymond E
Total Activity: $1,859,354
Largest Single Transaction
$336,165
by Cabillot Raymond E on Jan 27, 2025
30-Day Activity
18 Transactions
Volume: 42,179 shares
Value: $1,848,738
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Director, 10% Owner
|
Jan 30, 2025 | 1,100 | $49,511 | 318,652 (-0.3%) | Sale | |
|
Director, 10% Owner
|
Jan 28, 2025 | 5,381 | $224,065 | 319,752 (-1.7%) | Sale | |
|
Director, 10% Owner
|
Jan 27, 2025 | 8,077 | $336,165 | 325,133 (-2.5%) | Sale | |
|
Director, 10% Owner
|
Jan 24, 2025 | 1,436 | $59,508 | 333,210 (-0.4%) | Sale | |
|
Director
|
Jan 23, 2025 | 15 | $617 | 14,504 (+0.1%) | Grant | |
|
Director, 10% Owner
|
Jan 23, 2025 | 835 | $35,070 | 334,646 (-0.2%) | Sale | |
|
Director, 10% Owner
|
Jan 22, 2025 | 1,258 | $52,861 | 336,494 (-0.4%) | Sale | |
|
Director, 10% Owner
|
Jan 22, 2025 | 66 | $2,937 | 345,481 (-0.0%) | Sale | |
|
Director, 10% Owner
|
Jan 22, 2025 | 947 | $40,740 | 335,547 (-0.3%) | Sale | |
|
Director, 10% Owner
|
Jan 21, 2025 | 2,594 | $119,480 | 337,752 (-0.8%) | Sale | |
|
Director, 10% Owner
|
Jan 21, 2025 | 4,337 | $193,907 | 340,346 (-1.3%) | Sale | |
|
Director, 10% Owner
|
Jan 17, 2025 | 2,807 | $124,631 | 348,696 (-0.8%) | Sale | |
|
Director, 10% Owner
|
Jan 17, 2025 | 4,013 | $181,307 | 344,683 (-1.2%) | Sale | |
|
Director, 10% Owner
|
Jan 16, 2025 | 1,493 | $66,050 | 351,503 (-0.4%) | Sale | |
|
Director, 10% Owner
|
Jan 15, 2025 | 1,879 | $84,893 | 352,996 (-0.5%) | Sale | |
|
Director, 10% Owner
|
Jan 14, 2025 | 1,147 | $51,821 | 354,875 (-0.3%) | Sale | |
|
Director, 10% Owner
|
Jan 13, 2025 | 3,624 | $169,096 | 356,022 (-1.0%) | Sale | |
|
Director, 10% Owner
|
Jan 10, 2025 | 1,200 | $57,312 | 359,646 (-0.3%) | Sale | |
|
Director
|
Nov 22, 2024 | 4,250 | $116,875 | 17,687 (+24.0%) | Exercise/Conversion | |
|
Director
|
Nov 22, 2024 | 3,198 | $149,507 | 14,489 (-22.1%) | Payment of Exercise Price | |
|
Director
|
Nov 20, 2024 | 1,000 | $10,000 | 1,000 (+100.0%) | Grant | |
|
Chief Financial Officer
Officer
|
Nov 20, 2024 | 1,000 | $10,000 | 16,339 (+6.1%) | Grant | |
|
Chief Executive Officer
Director, Officer
|
Nov 20, 2024 | 1,000 | $10,000 | 99,779 (+1.0%) | Grant | |
|
Director, 10% Owner
|
Nov 20, 2024 | 1,000 | $10,000 | 96,613 (+1.0%) | Grant | |
|
Director
|
Nov 20, 2024 | 1,000 | $1,000 | 3,300 (+30.3%) | Grant | |
|
Director
|
Nov 20, 2024 | 1,000 | $10,000 | 1,000 (+100.0%) | Grant | |
|
Director
|
Nov 20, 2024 | 1,000 | $10,000 | 1,000 (+100.0%) | Grant | |
|
Director
|
Nov 20, 2024 | 1,000 | $10,000 | 13,437 (+7.4%) | Grant | |
|
Chief Financial Officer
Officer
|
Nov 7, 2024 | 1,000 | $40,020 | 15,339 (-6.5%) | Sale |